Table 3.
Representative resistance-related genes assessed in the current study
| Gene | Protein name | Related drug | Mechanism | Ref. |
| ABCB1 | ATP-dependent translocase | Multiple drugs | ↑, drug efflux pump | UniProt no. P08183; [14] |
| ASS1 | Argininosuccinate synthase | Platinum-based drugs | ↓, metabolic reprogramming | UniProt no. P00966; [15-17] |
| ATP7A | Copper-transporting ATPase 1 | Platinum-based drugs | Drug sequestration/efflux | UniProt no. Q04656; [18] |
| dCK | Deoxycytidine kinase | Pyrimidine antimetabolites | Mut, ↓, prevents drug activation | UniProt no. P27707; [19] |
| ECHDC1 | Ethylmalonyl-CoA decarboxylase | Gemcitabine | ↑, altered metabolism | UniProt no. Q9NTX5; [20] |
| hENT1 | Equilibrative nucleoside transporter 1 | Gemcitabine | ↓; reduced drug uptake | UniProt no. Q99808; [21] |
| MT2A | Metallothionein-2 | Platinum-based drugs | ↓; drug inactivation | UniProt no. P02795; [22] |
| SAT1 | Diamine acetyltransferase 1 | Cisplatin | ↓; altered polyamine metabolism | UniProt no. P21673; [17] |
| SLC3A1 | Neutral and basic amino acid transport protein | Several drugs, incl. cisplatin and doxorubicin | ↑, altered nutrient transport | UniProt no. Q07837; [23] |
| TUBβ3 | Tubulin βIII | Tubulin-interacting agents | ↑, mut, altered drug target | UniProt no. Q13509; [24] |
↑: Upregulated; ↓: downregulated, mut: mutated. ATP: Adenosine triphosphate.